Kyowa Kirin Co Ltd
TSE:4151

Watchlist Manager
Kyowa Kirin Co Ltd Logo
Kyowa Kirin Co Ltd
TSE:4151
Watchlist
Price: 2 569 JPY 0.06% Market Closed
Market Cap: 1.4T JPY
Have any thoughts about
Kyowa Kirin Co Ltd?
Write Note

Relative Value

The Relative Value of one Kyowa Kirin Co Ltd stock under the Base Case scenario is 3 246.37 JPY. Compared to the current market price of 2 569 JPY, Kyowa Kirin Co Ltd is Undervalued by 21%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
3 246.37 JPY
Undervaluation 21%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
92
vs Industry
33
Median 3Y
3.8
Median 5Y
4.2
Industry
2.6
Forward
2.7
vs History
95
vs Industry
23
Median 3Y
26.6
Median 5Y
27
Industry
23
Forward
19.1
vs History
85
vs Industry
26
Median 3Y
17.9
Median 5Y
21
Industry
17.8
vs History
52
vs Industry
17
Median 3Y
30.3
Median 5Y
43.8
Industry
25.4
vs History
88
vs Industry
39
Median 3Y
2
Median 5Y
2
Industry
2.2
vs History
88
vs Industry
37
Median 3Y
3
Median 5Y
3.5
Industry
2.8
Forward
2.2
vs History
88
vs Industry
48
Median 3Y
3.9
Median 5Y
4.6
Industry
5.4
vs History
92
vs Industry
32
Median 3Y
14.8
Median 5Y
15.5
Industry
13.7
Forward
9.2
vs History
93
vs Industry
31
Median 3Y
19.2
Median 5Y
20.6
Industry
17.2
Forward
11.2
vs History
80
vs Industry
30
Median 3Y
14.2
Median 5Y
18.4
Industry
16.5
vs History
61
vs Industry
21
Median 3Y
21.1
Median 5Y
29.3
Industry
19.3
vs History
88
vs Industry
34
Median 3Y
2.1
Median 5Y
2.2
Industry
2

Multiples Across Competitors

Competitors Multiples
Kyowa Kirin Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Kyowa Kirin Co Ltd
TSE:4151
1.4T JPY 2.8 13.9 7.6 9.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
JP
Kyowa Kirin Co Ltd
TSE:4151
Average P/E: 30.9
13.9
5%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top